Acute Injury Global Clinical Trials Review, H2, 2015

Introduction

Acute Injury Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Acute Injury Global Clinical Trials Review, H2, 2015" provides an overview of Acute Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Acute Injury Global Clinical Trials Review, H2, 2015

• Table of Contents

  Table of Contents 2

  List of Tables 3

  List of Figures 3

  Report Guidance 4

  Clinical Trials by Region 5

  Clinical Trials and Average Enrollment by Country 6

  Top Countries Contributing to Clinical Trials in Asia-Pacific 8

  Top Five Countries Contributing to Clinical Trials in Europe 9

  Top Countries Contributing to Clinical Trials in North America 10

  Top Countries Contributing to Clinical Trials in Middle East and Africa 11

  Clinical Trials by G7 Countries: Proportion of Acute Injury to Other Diseases Clinical Trials 12

  Clinical Trials by Phase in G7 Countries 13

  Clinical Trials in G7 Countries by Trial Status 14

  Clinical Trials by E7 Countries: Proportion of Acute Injury to Other Diseases Clinical Trials 15

  Clinical Trials in E7 Countries by Trial Status 16

  Clinical Trials by Phase 17

  In Progress Trials by Phase 18

  Clinical Trials by Trial Status 19

  Clinical Trials by End Point Status 20

  Subjects Recruited Over a Period of Time 21

  Clinical Trials by Sponsor Type 22

  Prominent Sponsors 23

  Top Companies Participating in Acute Injury Therapeutics Clinical Trials 25

  Prominent Drugs 27

  Clinical Trial Profile Snapshots 28

  Appendix 36

  Abbreviations 36

  Definitions 36

  Research Methodology 37

  Secondary Research 37

  About GlobalData 38

  Contact Us 38

  Disclaimer 38

  Source 39

List Of Tables
in Acute Injury Global Clinical Trials Review, H2, 2015

List of Tables

Acute Injury Therapeutics, Global, Clinical Trials by Region, 2015* 5

Acute Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Acute Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Acute Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8

Acute Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9

Acute Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 10

Acute Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11

Proportion of Acute Injury to Other Diseases Clinical Trials, G7 Countries (%), 2015* 12

Acute Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Acute Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Acute Injury to Other Diseases Clinical Trials, E7 Countries (%), 2015* 15

Acute Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 16

Acute Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 17

Acute Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18

Acute Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Acute Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Acute Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Acute Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Acute Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Acute Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Acute Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

List Of Figures, Charts and Diagrams
in Acute Injury Global Clinical Trials Review, H2, 2015

List of Figures

Acute Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 5

Acute Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Acute Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Acute Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8

Acute Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9

Proportion of Acute Injury to Other Diseases Clinical Trials, G7 Countries (%), 2015* 12

Acute Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Acute Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Acute Injury to Other Diseases Clinical Trials, E7 Countries (%), 2015* 15

Acute Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 16

Acute Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17

Acute Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18

Acute Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Acute Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Acute Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Acute Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Acute Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Acute Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Acute Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 37

Additional Details

Publisher

Global Data

Publisher Information

Reference

17700 | GDHC3063CTIDB

Number of Pages

39

Report Format

PDF

Related Reports